KRAS

KRAS proto-oncogene, GTPase

Tier: Cilia-Associated Genes

Ensembl:
ENSG00000133703
UniProt:
P01116
OMIM:
190070
Synonyms:
K-RAS4B, KRAS1, KRAS2

Cilia effects upon perturbation of KRAS

Cilia number / % ciliated:
Decreased cilia number
Loss-of-function effect:
Incrased cilia number

Ciliogenesis screen results (3 screens)

  • Wheway et al. 2015 (siRNA) [siRNA]: Ciliogenesis Defect (z=-6.08) PMID:26167766
  • Breslow et al. 2018 (CRISPR) [CRISPR]: Positive Regulator (Hh signaling, casTLE effect=-1.02) PMID:29459680
  • Elliott et al. 2025 (CRISPRa) [CRISPRa]: Disassembly Trigger (casTLE Effect=-2.90) PMID:41160700

Subcellular localization

lysosomes

References: PMID:19147554, PMID:32571902

Functional category

  • Ciliary assembly/disassembly
  • Trafficking (BBSome, small GTPases, vesicular transport, ATPases)
  • Actin & cytoskeleton regulation
  • Neurogenesis & migration
  • Signaling (Hedgehog, GPCRs, ion channels)
  • Cardiac & muscle development
  • Transcription regulation

Function

Inhibition of Kras effector pathways restored ciliogenesis in a mouse pancreatic cancer cell line, raising the possibility that ciliogenesis may be actively repressed by oncogenic Kras ( 19147554). Constitutive activation of KRAS promotes acinar-to-ductal metaplasia (ADM) but is associated with fewer primary cilia, and KRAS knockdown significantly increased cilia formation, suggesting that KRAS signalling suppresses ciliogenesis during ADM. (32571902)